Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

VIDEO: Expert Insights Ep 02 - Frank Holmes, CEO/CIO U.S. Global Investors & Executive Chairman, Hiv

This series showcases leaders in the industry giving insights into top stories, market sentiment, and trends. In this episode, Stockhouse sits down with Frank Holmes, CEO/CIO U.S.Global Investors & Executive Chairman, HIVE Blockchain Technologies Inc . ( TSX: V.HIVE , ...
Stockhouse Editorial | March 26, 2019 |

Buzz on the Bullboards: TSX struggles, interest rates, U.S. volatility

This week has been challenging for the TSX , which had seen a downturn after reaching new highs last week. The market’s performance has been influenced by the Bank of Canada’s decision to cut its benchmark interest rate by 50 basis points,...
Jonathon Brown | October 24, 2024 |

Oil Price Fundamental Daily Forecast – U.S. Supply Will Control Price Action This Week

The late price behavior on Friday and early Monday suggests crude oil traders have fully priced in the Phase One trade agreement. This means that investors will be looking for further news to push prices through the important technical resistance levels in order to extend the...
FX Empire | December 16, 2019 |

Tariffs Are Having a Bigger Effect on U.S. Manufacturing Than Initially Thought

The U.S. manufacturing sector contracted for the fifth straight month in December, with the monthly reading from the Institute for Supply Management (ISM) hitting its weakest point in more than 10 years. The purchasing manager’s index (PMI) fell to 47.2,...
Frank Holmes | January 8, 2020 |

Will U.S. Shale Survive If Oil Hits $40?

Within a month, the U.S. oil benchmark West Texas Intermediate recorded two first-of-a-kind events. First, it fell below zero on April 20. Then, it soared up so high it is about to book its best month ever, CNBC's Pippa Stevens noted in a recent commentary. Still, many ...
Irina Slav | May 28, 2020 |

The U.K. Just Said No to EU Socialism. Will U.S. Voters Do the Same in 2020?

Let’s begin with a thought experiment. Imagine you wake up tomorrow from a three and a half-year coma. Everything that’s happened in the meantime—the election of Donald Trump, impeachment, Brexit and more—is a complete mystery to you....
Frank Holmes | December 23, 2019 |

Buzz on the Bullboards: WEED announces $3.4B U.S. acquisition

Investors visit the Stockhouse Bullboards (naturally) to talk stocks. But they also come to the Bullboards to post and swap information with other investors. An example of the latter took place yesterday on the Bullboard of Aurora Cannabis Inc ( TSX: ACB , NYSE: ACB , Foru...
Stockhouse Editorial | April 18, 2019 |

U.S. Treasury Removes China as Currency Manipulator

The U.S. has formally removed China as a currency manipulator, just ahead of the signing of the ‘Phase 1’ deal. Given its past record, will China really change its ways? Kenny Fisher There was another positive develop...
FX Empire | January 14, 2020 |

Trial Milestone Reached; U.K.-Based Biopharma Gets $15 Million

The first patient has been treated in the second cohort of a Phase 2 study of a gene therapy targeting Parkinson's disease, explained an H.C. Wainwright & Co. report. In an April 30 research note, analyst Joseph Pantginis reported that Oxford Biomedica Plc ...
Streetwise Reports | May 9, 2019 |

How to Limit Your Exposure to the U.S.-China Trade War

The U.S. economy is growing at one of the fastest rates in the developed world right now, and unemployment hit a nearly 50-year low of 3.6 percent in April. Under normal circumstances, this should boost demand for domestic equities. Some investors, however, are hesitant t...
Frank Holmes | May 10, 2019 |
1 2 3 4 5 6 7 8 9 10 ...